Medindia

X

New BioTrends Report Highlights the Current Treatment Approaches and Major Drivers of Prescribing Choice for Noninfectious Uveitis

Tuesday, August 24, 2010 General News J E 4
Advertisement

BioTrends Research Group, Inc.

Sharon Funk

404-223-2963

sfunk@bio-trends.com

Decision Resources, Inc.

Christopher Comfort

781-296-2597

ccomfort@dresources.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Latest BioTrends Report Provides Comprehensive Mar...
S
Regenicin Appoints Amgen Co-founder Dr. Joseph Rub...